Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V R Fantin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncogene|August 8, 2006
Mitochondriotoxic compounds for cancer therapyV R Fantin, P Leder
American Journal of Physiology. Endocrinology and Metabolism|January 25, 2000
Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasisV R Fantin, Q Wang, G E Lienhard, et al.
Biochemical and Biophysical Research Communications|July 15, 1999
Insulin receptor substrate 4 supports insulin- and interleukin 4-stimulated proliferation of hematopoietic cellsV R Fantin, S R Keller, G E Lienhard, et al.
Oncogene|October 26, 2010
Cancer-associated IDH mutations: biomarker and therapeutic opportunitiesK E Yen, M A Bittinger, S M Su, et al.
The Journal of Biological Chemistry|May 30, 1998
Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cellsV R Fantin, J D Sparling, J W Slot, et al.
The Journal of Biological Chemistry|August 22, 1997
A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate familyB E Lavan, V R Fantin, E T Chang, et al.
Endocrinology|March 6, 1999
Cloning, tissue expression, and chromosomal location of the mouse insulin receptor substrate 4 geneV R Fantin, B E Lavan, Q Wang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncogene|August 8, 2006
Mitochondriotoxic compounds for cancer therapyV R Fantin, P Leder
American Journal of Physiology. Endocrinology and Metabolism|January 25, 2000
Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasisV R Fantin, Q Wang, G E Lienhard, et al.
Biochemical and Biophysical Research Communications|July 15, 1999
Insulin receptor substrate 4 supports insulin- and interleukin 4-stimulated proliferation of hematopoietic cellsV R Fantin, S R Keller, G E Lienhard, et al.
Oncogene|October 26, 2010
Cancer-associated IDH mutations: biomarker and therapeutic opportunitiesK E Yen, M A Bittinger, S M Su, et al.
The Journal of Biological Chemistry|May 30, 1998
Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cellsV R Fantin, J D Sparling, J W Slot, et al.
The Journal of Biological Chemistry|August 22, 1997
A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate familyB E Lavan, V R Fantin, E T Chang, et al.
Endocrinology|March 6, 1999
Cloning, tissue expression, and chromosomal location of the mouse insulin receptor substrate 4 geneV R Fantin, B E Lavan, Q Wang, et al.
Pageof 1